FDA Approved: BEYFORTUS — Original Application (Sanofi Vaccines US Inc.)

View source ↗

Summary

FDA approved Beyfortus (nirsevimab) from an original application to prevent respiratory syncytial virus lower respiratory tract disease in healthy term and pret…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infection

Drugs mentioned

• BEYFORTUS (Nirsevimab)

Snippet

ORIG AP for BEYFORTUS (NIRSEVIMAB)